Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of out-of-hospital cardiac arrest in patients with rheumatoid arthritis: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Three decades of heart transplantation: experience and long-term outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Oxygen Uptake During Activities of Daily Life in Patients Treated With a Left Ventricular Assist Device

    Research output: Contribution to journalJournal articleResearchpeer-review

  • PREFER investigators
View graph of relations

OBJECTIVE: To assess current management practice of heart failure with reduced ejection fraction (HFrEF) in multinational primary care (PC) and determine whether N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP)-guided referral of HFrEF patients from PC to a cardiologist could improve care, defined as adherence to European Society of Cardiology (ESC) guideline-recommended pharmacotherapy.

METHODS: PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic HF in PC (PREFER) study enrolled HFrEF patients from PC considered clinically stable and those with NT-pro-BNP ≥600 pg/mL were referred to a cardiologist for optimisation of HF treatment. The primary outcome of adherence to ESC HF guidelines after referral to specialist was assessed at the second visit within 4 weeks of cardiologist's referral and no later than 6 months after the baseline visit. Based on futility interim analysis, the study was terminated early.

RESULTS: In total, 1415 HFrEF patients from 223 PCs from 18 countries in Europe were enrolled. Of these, 1324 (96.9%) were considered clinically stable and 920 (65.0%) had NT-pro-BNP ≥600 pg/mL (mean: 2631 pg/mL). In total, 861 (60.8%) patients fulfilled both criteria and were referred to a cardiologist. Before cardiologist consultation, 10.1% of patients were on ESC guideline-recommended HFrEF medications and 2.7% were on recommended dosages of HFrEF medication (defined as ≥50% of ESC guideline-recommended dose). Postreferral, prescribed HFrEF drugs remained largely unchanged except for an increase in diuretics (+4.6%) and mineralocorticoid receptor antagonists (+7.9%). No significant increase in patients' adherence to guideline-defined drug combinations (11.2% post-referral vs 10.1% baseline) or drug combinations and dosages (3.3% postreferral vs 2.7% baseline) was observed after cardiologist consultation.

CONCLUSIONS: PREFER demonstrates substantial suboptimal treatment of HFrEF patients in the real world. Referral of patients with elevated NT-pro-BNP levels from PC to cardiologist did not result in meaningful treatment optimisation for treatments with known mortality and morbidity benefit.

Original languageEnglish
Article numbere001630
JournalOpen Heart
Volume8
Issue number2
ISSN2053-3624
DOIs
Publication statusPublished - Oct 2021

Bibliographical note

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 71203445